Brian Porter
Impact in
- Rheumatology top 0.2%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Immunology top 1%
- Psoriasis: Treatment and Pathogenesis
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Rheumatology 56
- Spondyloarthritis Studies and Treatments 53
- Rheumatoid Arthritis Research and Therapies 24
- Immunology 22
- Psoriasis: Treatment and Pathogenesis 12
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 7
- Immunotherapy and Immune Responses 4
- Co-authors
- Atul Deodhar (28 shared papers)Thomas R. Malek (7 shared papers)Xenofon Baraliakos (21 shared papers)Hanno B. Richards (10 shared papers)Jürgen Braun (20 shared papers)Mats Andersson (8 shared papers)Joachim Sieper (12 shared papers)Ruvie Martin (10 shared papers)
- Journals
- Annals of the Rheumatic Diseases (23 papers)Lara D. Veeken (6 papers)AIDS (4 papers)Arthritis Research & Therapy (4 papers)The Journal of Rheumatology (3 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Brian Porter
90 papers receiving 3.7k citations
Brian Porter's Hit Papers
Peers
Comparison fields: 5 of 114
- Rheumatology 2.0k
- Immunology 1.6k
- Hematology 612
- Virology 114
- Dermatology 129
Countries citing papers authored by Brian Porter
This map shows the geographic impact of Brian Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Porter more than expected).
Fields of papers citing papers by Brian Porter
This network shows the impact of papers produced by Brian Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Porter. The network helps show where Brian Porter may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis Hit paper breakdown → | 2015 | 768 |
| 2 | Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data Hit paper breakdown → | 2019 | 219 |
| 3 | 2017 | 168 | |
| 4 | 2010 | 149 | |
| 5 | 2019 | 142 | |
| 6 | 2016 | 135 | |
| 7 | 2000 | 133 | |
| 8 | 2020 | 117 | |
| 9 | 2018 | 113 | |
| 10 | 2018 | 110 | |
| 11 | 2014 | 96 | |
| 12 | 2018 | 86 | |
| 13 | 2013 | 78 | |
| 14 | 2017 | 77 | |
| 15 | 2011 | 69 | |
| 16 | Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial. | 2018 | 69 |
| 17 | 2016 | 65 | |
| 18 | 1999 | 57 | |
| 19 | 1999 | 49 | |
| 20 | IL-2Rbeta/IL-7Ralpha doubly deficient mice recapitulate the thymic and intraepithelial lymphocyte (IEL) developmental defects of gammac-/- mice: roles for both IL-2 and IL-15 in CD8alphaalpha IEL development. | 1999 | 43 |
About Brian Porter
Brian Porter is a scholar working on Rheumatology, Immunology, Hematology, Surgery and Epidemiology, having authored 91 papers that have together received 3.8k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (53 papers), Rheumatoid Arthritis Research and Therapies (24 papers), Psoriasis: Treatment and Pathogenesis (12 papers), Autoimmune and Inflammatory Disorders Research (9 papers), Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (7 papers), Infectious Diseases and Tuberculosis (7 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Rheumatology (2.0k citations), Immunology (1.6k citations), Hematology (612 citations), Virology (114 citations) and Dermatology (129 citations). Brian Porter has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Atul Deodhar, Thomas R. Malek, Xenofon Baraliakos, Hanno B. Richards, Jürgen Braun, Mats Andersson, Joachim Sieper, Ruvie Martin, Paul Emery and Dominique Baeten. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, AIDS, Arthritis Research & Therapy and The Journal of Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.